Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 109 Endometrial Neoplasms 16 Neoplasm Metastasis 10 Polycystic Ovary Syndrome 9 Ovarian Neoplasms 7 Neoplasms 7 Advanced Breast Cancer 5 Triple Negative Breast Neoplasms 4 Prostatic Neoplasms 4 Fallopian Tube Neoplasms 4 Recurrence 3 Infertility 3 Carcinoma, Intraductal, Noninfiltrating 3 Breast Neoplasms, Male 3 Squamous Cell Carcinoma of Head and Neck 2 Progesterone Resistance 2 Neoplasms by Site 2 Hereditary Sensory and Autonomic Neuropathies 2 Head and Neck Neoplasms 2 HR+/HER2- Breast Cancer 2 Estrogen Receptor-positive Breast Cancer 2 Endometrial Hyperplasia 2 Cystadenocarcinoma, Serous 2 Carcinoma, Non-Small-Cell Lung 2 Breast Diseases 2 Breast Cancer Metastatic 2 Breast Cancer Female 2 Uterine Cervical Neoplasms 1 Unilateral Breast Neoplasms 1 Small Cell Lung Carcinoma 1

Interventions

Specimen Handling 8 Tamoxifen 6 Standard of Care 4 Practice Guidelines as Topic 4 Radiotherapy 3 Methods 3 Sentinel Lymph Node Biopsy 2 Radiation Dose Hypofractionation 2 Radiation 2 Educational Status 2 Early Intervention, Educational 2 Counseling 2 ruxolitinib 1 pembrolizumab 1 exemestane 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 auricularum 1 abemaciclib 1 Watchful Waiting 1 Telemedicine 1 Taxes 1 Tablets 1 Surveys and Questionnaires 1 Starch 1 Reverse Transcriptase Polymerase Chain Reaction 1 Ranitidine 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Radiosurgery 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Carcinoma In Situ × Letrozole × 1 year × Clear all

NCT06671912 2026-06-02

LoTam

Alliance for Clinical Trials in Oncology

Phase 3 Suspended

Breast Carcinoma In Situ

Data powered by HemOnc (CC BY 4.0) Colophon ⚡